The Washington Commanders will start Josh Johnson at quarterback for their game against the Dallas Cowboys on Christmas Day, ruling out Marcus Mariota because of a quad injury. Johnson will make his ...
In the middle of the Denver Nuggets' fourth-quarter action against the Dallas Mavericks, starting forward Cam Johnson went down with what the team labeled as a right knee sprain and wound up not ...
Johnson & Johnson is rated a buy, with accelerating revenue and earnings growth driven by TREMFYA, CARVYKTI, and robust MedTech innovation. JNJ's portfolio reshaping (divesting Orthopaedics and ...
A California jury ordered Johnson & Johnson to pay $40 million to two women who claimed its talc-based baby powder caused their ovarian cancer. The women testified that decades of use led to major ...
Dec 12 (Reuters) - A California jury on Friday awarded $40 million to two women who said Johnson & Johnson’s (JNJ.N), opens new tab baby powder was to blame for their ovarian cancer. The jury in Los ...
LSU senior guard Flau’jae Johnson is a true creative in every sense of the word — even down to the way she makes cereal. On Monday morning, Johnson gave a behind-the-scenes look at how she makes the ...
Speaker Mike Johnson is a political survivor, weathering crisis after crisis since his unlikely ascent two years ago. But now, the battered House leader is entering what could be the most difficult ...
House Speaker Mike Johnson (R-La.) opened up in a revealing Wednesday interview alongside his wife Kelly, sharing some of the challenges he has faced since taking the reins of the lower chamber amid ...
Johnson has maintained that he is "following the Pelosi precedent." Speaker Mike Johnson is resisting calls to swear in Democratic Rep.-elect Adelita Grijalva, saying Monday that he will administer ...
Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes—the latest attempt to slim down by the healthcare giant.
Oct 10 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab is in discussions to buy Protagonist Therapeutics (PTGX.O), opens new tab, a source familiar with the matter told Reuters. Shares of ...